Answers are grounded in this paper and cite their sources.
Cardiac resynchronization therapy is recognized to improve functional class, quality of life, and mortality in heart failure patients.
Cardiac resynchronization therapy has been shown to improve the functional class and quality of life, reduce mitral regurgitation, and remodel the heart favourably, while reducing heart failure hospitalization and overall mortality in this large subgroup of heart failure (HF) patients.
No takes yet. Share an insight, caveat, or question.
Jagmeet P. Singh (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: